Aspartyl protease inhibitors

Details for Australian Patent Application No. 2006259609 (hide)

Owner Schering Corporation Pharmacopeia Drug Discovery, Inc.

Inventors Stamford, Andrew W.; McKittrick, Brian; Le, Thuy X.H.; Zhu, Zhaoning; Guo, Tao

Agent Griffith Hack

Pub. Number AU-A-2006259609

PCT Pub. Number WO2006/138217

Priority 60/690,538 14.06.05 US

Filing date 12 June 2006

Wipo publication date 28 December 2006

International Classifications

C07D 239/70 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138217 Priority application(s): WO2006/138217

31 January 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name of Pharmacopeia Drug Discovery, Inc. and Schering Corporation, Application No. 2006259609, under INID (71), corrected the applicant name to Pharmacopeia, Inc. and Schering Corporation.

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259619-Modified and immediate release memantine bead formulation

2006259606-Nanoparticulate clopidogrel and aspirin combination formulations